Loading...
In a randomized, controlled, double-blind trial, researchers in Poland evaluated the efficacy of the probiotic Lactobacillus reuteri for treatment of acute gastroenteritis (AGE) in young children. Ninety-one otherwise healthy patients <5 years old with presumed AGE (defined as change in stool consistency, frequency, or both)- received a daily dose of either Lactobacillus reuteri or placebo for 5 days. The primary outcome was time to resolution of diarrhea (back to normal stool consistency or normal number of daily stools) and normal stool for 48 hours. Secondary outcomes included need for intravenous fluids and duration of hospitalization.
The duration of diarrhea was similar in both groups. All secondary outcomes were also similar in both g…